Should the loading dose of colistin be administered as a single bolus or divided over 24 hours?

Colistin Loading Dose Administration

The loading dose of colistin should be administered as a single bolus infusion over 3-5 minutes, not divided over 24 hours. 1

Dosing Regimen

The FDA-approved administration method is clear and unambiguous 1:

• Loading dose: Administer one-half of the total daily dose as a slow intravenous injection over 3-5 minutes
• Maintenance dosing: The remaining half is then added to IV fluids and infused continuously over 22-23 hours, starting 1-2 hours after the initial bolus

Evidence-Based Rationale

International guidelines strongly support a loading dose approach to achieve therapeutic concentrations rapidly. The 2022 Taiwan guidelines recommend a loading dose of 9 MU (5 mg/kg) of colistin followed by maintenance doses of 4.5 MU twice daily in critically ill patients 2. This recommendation carries a strong rating despite low-quality evidence, reflecting the clinical importance of rapid therapeutic levels.

Pharmacokinetic Justification

The necessity of a bolus loading dose is driven by colistin's pharmacokinetics:

• Long half-life: Colistin has an elimination half-life of approximately 18.5 hours 3
• Delayed steady state: Without a loading dose, therapeutic concentrations are not achieved for 12-48 hours 3
• Improved outcomes: A 2022 multicenter study demonstrated that patients receiving a loading dose had significantly higher rates of favorable clinical outcomes (55.2% vs 35.8%, p=0.037) and microbiological eradication (50% vs 27.3%, p=0.042) at day 14 compared to those without loading doses 4

Practical Administration Protocol

For adults with normal renal function 1:

1. Initial bolus: Inject slowly over 3-5 minutes (this is half the total daily dose)
2. Wait period: 1-2 hours
3. Continuous infusion: Add remaining half to compatible IV solution and infuse over 22-23 hours

Alternative regimen (direct intermittent): Administer one-half of total daily dose over 3-5 minutes every 12 hours 1

Critical Monitoring Considerations

Renal function must be monitored closely during colistin therapy 2. The evidence shows conflicting nephrotoxicity signals:

• One study found 52.6% nephrotoxicity with loading doses versus 20.5% without (p=0.001) 5
• However, another multicenter study found no significant difference in acute kidney injury risk between loading and non-loading groups 4

The panel strongly recommends avoiding concomitant nephrotoxic or ototoxic drugs with colistin 6.

Dosing Adjustments

Renal impairment requires dose modification 1:

• Severe impairment (CrCl 10-29 mL/min): 1.5 mg/kg every 36 hours
• Moderate impairment (CrCl 30-49 mL/min): 2.5 mg/kg once daily or divided into 2 doses
• Mild impairment (CrCl 50-79 mL/min): 2.5-3.8 mg/kg divided into 2 doses

Common Pitfalls to Avoid

• Do not divide the loading dose over 24 hours - this defeats the purpose of rapidly achieving therapeutic levels
• Pay attention to dosing units: CMS dosing uses different units (1 million U = 80 mg mass CMS = 33 mg CBA) 6
• Base dosing on ideal body weight in obese patients 1
• Do not delay the loading dose - pharmacokinetic modeling shows that delaying therapeutic concentrations by avoiding a loading dose reduces time to bacterial kill by half 3